According to Ryman Healthcare's latest financial reports the company's current EPS (TTM) is HK$2.43. In 2023 the company made an earnings per share (EPS) of HK$2.43 a decrease over its 2022 EPS that were of HK$7.09.
Year | EPS | Change |
---|---|---|
2023 | HK$2.43 | -65.64% |
2022 | HK$7.09 | 63.32% |
2021 | HK$4.34 | 86.07% |
2020 | HK$2.33 | -28.55% |
2019 | HK$3.26 | -20.76% |
2018 | HK$4.12 | 12.45% |
2017 | HK$3.66 | 18.39% |
2016 | HK$3.09 | 16.17% |
2015 | HK$2.66 | 7.38% |
2014 | HK$2.48 | 47.85% |
2013 | HK$1.68 | 14.47% |
2012 | HK$1.47 | 30.42% |
2011 | HK$1.12 | 37.12% |
2010 | HK$0.82 | 49.93% |
2009 | HK$0.55 | -34.99% |
2008 | HK$0.84 | 79.81% |
2007 | HK$0.47 | 47.89% |
2006 | HK$0.32 | 28.53% |
2005 | HK$0.25 | 36.66% |
2004 | HK$0.18 | 32.55% |
2003 | HK$0.14 | 38.3% |
2002 | HK$0.09816 | -21.49% |
2001 | HK$0.13 | 6.66% |
2000 | HK$0.12 | 113.57% |
1999 | HK$0.05489 |